RE:RE:RE:RE:Acquisition + insider buying = high stock price +short coverYou are clueless about how long a bill takes to become a law. There are public consultations that have to take place, which will include Pharma, committee review, regulations that have yet to be drafted. Once that is all done the bill gets voted on in the House of Commons and goes to the House of Lords. They get to review it again and can send it back to the House with revisions.
The House then has to consider the changes and vote on it again and send it back to the House of Lords. If approved, it then goes to the Queen for Royal assent. Best case scenario for this bill will become law at end of 2017. All bets are off if there is is an election in the interim. Let's not forget that the bill does not contemplate retroactive price revisions. Finally, the company has indicated recently that only about 9% of their portfolio in the U.K. Is potentially impacted by the bill. All of this doesn't sound as bad as you short and distort gang make it out to be.
Craigbad wrote: Maybe the second reading of the UK bill this month, the lawsuits going to court and taxloss selling should be positive for the stock as well?
GOODNEWZ wrote: Thank you. I've been reading the disaster here but decided now is the right time to jump in.
Do you understand that if the CEO starts buying and acquisitions are announced, you Mr. Obnoxious Famous Wall Street Short won't be able to post here anymore? Your time is almost done! But if your actions continue to drive down the price and margins are triggered again, the stock will go down some more but it's already well oversold. How low can it go? We will see soon, very soon. This has hit a breking point and the recovery will be very interesting.
We might both agree on something: The CEO was given some very bad advice on how to handle his own shares in the company. And we probably both agree who that Wall Street Banker is.